EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples

View source ↗

Summary

EMA announces it has qualified the first artificial intelligence tool to diagnose metabolic dysfunction-associated steatohepatitis (MASH) in liver biopsy sample…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Snippet

Artificial intelligence tool reliably identifies disease severity and reduces variability